Name: PHAT Income Statement - Phathom Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

PHAT - Phathom Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

PHAT Income Statement - Phathom Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18
Revenues
Revenues	58.3	57.6	49.5	39.5	28.5	29.7	16.4	7.3	1.9	0.7	0.0	0.0	0.0	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Revenues
Revenues	204.9	175.1	55.3	0.7	0.0	-	-	-	-
Cost of Revenue	30.9	22.6	8.0	0.2	0.0	-	-	-	-
Gross Profit	174.0	152.5	47.3	0.5	0.0	-	-	-	-
Operating Expenses
Research & Development	31.4	32.8	34.1	49.9	71.4	72.3	98.1	20.4	0.0
Selling General & Administrative	239.3	279.7	290.7	117.9
Operating Income
Operating Income	(96.6)	(160.0)	(277.5)	(167.3)	(172.4)	(135.1)	(125.7)	(106.2)	(1.2)
Non-Operating
Interest Income	6.1	7.0	15.2	7.9	2.1	0.0	1.1	1.1	-
Interest Expense	65.8	68.1	72.0	42.0	27.3
Tax & Net
Income Tax Expense	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	(157.3)	(221.2)	(334.3)	(201.6)
Per Share
EPS Basic	(1.92)	(3.03)	(5.29)	(3.93)	(5.05)	(3.89)	-	-	-
EPS Diluted	(1.92)	(3.03)	(5.29)	(3.93)	(5.05)
Supplementary Data
EBITDA	-	(159.4)	(276.7)	(166.7)	(171.8)	(134.6)	(125.3)	(106.2)	(1.2)
EBIT	(96.6)	(160.0)	(277.5)	(167.3)	(172.4)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	7.8	7.5	7.0	9.1	9.2	8.6	8.7	7.4	9.4	13.4	12.3	12.8	11.5	15.9	19.0	18.8	17.7	13.6	16.6	21.6	20.6	41.7	25.8	14.9	15.9	12.7	4.5	2.8	0.4	-	0.0	-	-
Selling General & Administrative	54.0	48.4	51.6	85.3	94.5	76.7	76.1	75.9	62.0	57.0	23.4	18.9	18.6	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	23.4	18.9	18.6	30.7	23.5	26.5	20.2
Depreciation & Amortization	0.1	-	-	-	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.1
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	61.8	55.9	58.6	94.4	103.7	85.3	84.8	83.2	71.4	70.4	35.7	31.7	30.1	46.6	42.5	45.4

Operating Income
Operating Income	(15.5)	(5.9)	(15.3)	(59.9)	(78.9)	(59.4)	(70.8)	(77.3)	(70.0)	(69.9)	(35.7)	(31.7)	(30.1)	(46.6)	(42.5)	(45.4)	(37.9)	(33.0)	(33.1)	(35.3)	(33.6)	(52.4)	(32.8)	(20.0)	(20.4)	(15.7)	(6.3)	(83.0)	(1.2)	-	(0.3)	-	-

Non-Operating
Interest Income	1.7	1.2	1.4	1.8	2.6	3.5	3.7	3.6	4.3	3.3	2.7	0.3	1.5	1.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	-	0.4	0.1	-	-	-	-	-
Interest Expense	15.8	16.4	16.1	17.5	18.1	18.6	18.5	17.8	17.2	13.0	10.1	9.6	9.2	9.6	9.3	5.7	2.8	2.8
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(14.9)	(15.2)	(14.7)	(15.9)	(15.5)	(15.0)	(14.8)	(14.1)	(12.9)	(9.7)	(7.6)	(9.3)	(7.7)	(8.4)	(8.6)	(5.6)	(2.8)
Pre-Tax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Tax & Net
Income Tax Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	(30.4)	(21.1)	(30.0)	(75.8)	(94.3)	(74.5)	(85.6)	(91.4)	(82.9)	(79.6)	(43.2)	(41.0)	(37.8)	(55.0)	(51.1)	(50.9)	(40.7)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(30.4)	(21.1)	(30.0)	(75.8)	(94.3)	(74.5)	(85.6)	(91.4)	(82.9)	(79.6)	(43.2)	(41.0)	(37.8)	(55.0)	(51.1)	(50.9)	(40.7)
Net Income Attributable To Parent	(30.4)	(21.1)	(30.0)	(75.8)	(94.3)	(74.5)	(85.6)	(91.4)	(82.9)	(79.6)	(43.2)	(41.0)	(37.8)	(55.0)	(51.1)	(50.9)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(30.4)	(21.1)	(30.0)	(75.8)	(94.3)	(74.5)	(85.6)	(91.4)	(82.9)	(79.6)	(43.2)	(41.0)	(37.8)	(55.0)	(51.1)

Per Share
EPS Basic	(0.37)	-	(0.41)	(1.05)	(1.31)	-	(1.32)	(1.56)	(1.42)	-	(0.76)	(0.84)	(0.89)	-	(1.32)	(1.33)	(1.07)	-	(0.98)	(1.00)	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	(0.37)	-	(0.41)	(1.05)	(1.31)	-	(1.32)	(1.56)	(1.42)	-	(0.76)	(0.84)	(0.89)	-	(1.32)	(1.33)	(1.07)	-
Shares Basic	82.1	-	73.4	72.5	72.0	-	64.6	58.6	58.4	-	56.8	48.5	42.4	-	38.8	38.3	38.0	-
Shares Diluted	82.1	-	73.4	72.5	72.0	-	64.6	58.6	58.4	-	56.8	48.5	42.4	-	38.8	38.3	38.0	-

Supplementary Data
EBITDA	(15.4)	-	-	-	(78.7)	(59.2)	(70.6)	(77.1)	(69.7)	(69.6)	(35.6)	(31.6)	(29.9)	(46.5)	(42.3)	(45.3)	(37.8)	(32.9)	(33.0)	(35.2)	(33.5)	(52.3)	(32.7)	(19.9)	(20.3)	-	(6.3)	-	(1.2)	-	-	-	-
EBIT	(15.5)	(5.9)	(15.3)	(59.9)	(78.9)	(59.4)	(70.8)	(77.3)	(70.0)	(69.9)	(35.7)	(31.7)	(30.1)	(46.6)	(42.5)	(45.4)	(37.9)	(33.0)	(33.1)